Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arana G. W., Baldessarini R. J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiatry. 1985 Dec;42(12):1193–1204. doi: 10.1001/archpsyc.1985.01790350067012. [DOI] [PubMed] [Google Scholar]
- Bech P., Kastrup M., Rafaelsen O. J. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37. [PubMed] [Google Scholar]
- Bowden C. L. Current treatment of depression. Hosp Community Psychiatry. 1985 Nov;36(11):1192–1200. doi: 10.1176/ps.36.11.1192. [DOI] [PubMed] [Google Scholar]
- Carroll B. J., Feinberg M., Greden J. F., Tarika J., Albala A. A., Haskett R. F., James N. M., Kronfol Z., Lohr N., Steiner M. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 1981 Jan;38(1):15–22. doi: 10.1001/archpsyc.1981.01780260017001. [DOI] [PubMed] [Google Scholar]
- Cleghorn J. M. Formulation: a pedagogic antidote to DSM-III. Compr Psychiatry. 1985 Nov-Dec;26(6):504–512. doi: 10.1016/0010-440x(85)90017-3. [DOI] [PubMed] [Google Scholar]
- Coccaro E. F., Siever L. J. Second generation antidepressants: a comparative review. J Clin Pharmacol. 1985 May-Jun;25(4):241–260. doi: 10.1002/j.1552-4604.1985.tb02835.x. [DOI] [PubMed] [Google Scholar]
- Dupont W. D. Randomized vs. historical clinical trials. Are the benefits worth the cost? Am J Epidemiol. 1985 Dec;122(6):940–946. doi: 10.1093/oxfordjournals.aje.a114198. [DOI] [PubMed] [Google Scholar]
- Kielholz P., Terzani S., Gastpar M. Treatment for therapy resistant depressions. Int Pharmacopsychiatry. 1979;14(2):94–100. doi: 10.1159/000468363. [DOI] [PubMed] [Google Scholar]
- LABORIT H., HUGUENARD P., ALLUAUME R. Un nouveau stabilisateur végétatif; le 4560 RP. Presse Med. 1952 Feb 13;60(10):206–208. [PubMed] [Google Scholar]
- Møller S. E., Reisby N., Elley J., Krautwald O., Ortmann J., Larsen O. B. Biochemical and diagnostic classification and serum drug levels: relation to antidepressive effect of imipramine. Neuropsychobiology. 1985;13(4):160–166. doi: 10.1159/000118182. [DOI] [PubMed] [Google Scholar]
- Møller S. E. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments. Acta Psychiatr Scand Suppl. 1985;325:3–31. [PubMed] [Google Scholar]
- Parker G., O'Donnell M., Walter S. Changes in the diagnoses of the functional psychoses associated with the introduction of lithium. Br J Psychiatry. 1985 Apr;146:377–382. doi: 10.1192/bjp.146.4.377. [DOI] [PubMed] [Google Scholar]
- Pichot P. Nosological developments in European psychiatry and psychopharmacology. Pharmacopsychiatry. 1986 Jan;19(1):23–25. doi: 10.1055/s-2007-1017144. [DOI] [PubMed] [Google Scholar]
- Pöldinger W. Die biologisch-pharmakologisch orientierten Behandlungsmethoden der Depressionen unter besonderer Berücksichtigung der Anliegen der Praxis. Wien Klin Wochenschr. 1985 Feb 15;97(4):165–175. [PubMed] [Google Scholar]
- Talbott J. A. Presidential address: Our patients' future in a changing world: the imperative for psychiatric involvement in public policy. Am J Psychiatry. 1985 Sep;142(9):1003–1014. doi: 10.1176/ajp.142.9.1003. [DOI] [PubMed] [Google Scholar]
- Walton J. The science of clinical neurology. J R Soc Med. 1986 Jan;79(1):5–14. doi: 10.1177/014107688607900104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams J. B. The multiaxial system of DSM-III: where did it come from and where should it go? I. Its origins and critiques. Arch Gen Psychiatry. 1985 Feb;42(2):175–180. doi: 10.1001/archpsyc.1985.01790250069009. [DOI] [PubMed] [Google Scholar]